PARAMETRIC PORTFOLIO ASSOCIATES LLC - HORIZON PHARMA PLC ownership

HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of HORIZON PHARMA PLC
ValueSharesWeighting
Q1 2019$19,442,000
+43.2%
735,594
+5.9%
0.02%
+30.8%
Q4 2018$13,573,000
+5.1%
694,635
+5.3%
0.01%
+18.2%
Q3 2018$12,917,000
+12.1%
659,716
-5.2%
0.01%0.0%
Q2 2018$11,527,000
+18.2%
696,072
+1.4%
0.01%
+10.0%
Q1 2018$9,752,000
+1.1%
686,780
+3.9%
0.01%0.0%
Q4 2017$9,646,000
-3.8%
660,689
-16.4%
0.01%
-9.1%
Q3 2017$10,025,000
+108.1%
790,633
+94.8%
0.01%
+83.3%
Q2 2017$4,818,000
+115.2%
405,934
+167.9%
0.01%
+100.0%
Q1 2017$2,239,000
-13.6%
151,507
-5.4%
0.00%
-25.0%
Q4 2016$2,592,000
-77.9%
160,193
-75.3%
0.00%
-77.8%
Q3 2016$11,744,000
+39.9%
647,783
+27.1%
0.02%
+38.5%
Q2 2016$8,397,000
-15.4%
509,860
-14.9%
0.01%
-18.8%
Q1 2016$9,926,000
+51.2%
599,021
+97.7%
0.02%
+45.5%
Q4 2015$6,564,000
-0.1%
302,929
-8.6%
0.01%
-15.4%
Q3 2015$6,568,000
+20.1%
331,400
+110.5%
0.01%
+18.2%
Q2 2015$5,468,000
+67.8%
157,406
+25.4%
0.01%
+57.1%
Q1 2015$3,259,000
+224.6%
125,510
+61.1%
0.01%
+250.0%
Q4 2014$1,004,000
-33.3%
77,903
-36.4%
0.00%
-33.3%
Q3 2014$1,505,000122,5800.00%
Other shareholders
HORIZON PHARMA PLC shareholders Q1 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,959,819$96,430,00010.71%
Consonance Capital Management LP 5,793,903$93,745,00010.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,956,988$144,924,0005.96%
JW Asset Management, LLC 507,075$8,205,0005.46%
KINGDON CAPITAL MANAGEMENT, L.L.C. 6,682,618$108,125,0005.23%
NEXTHERA CAPITAL LP 500,000$8,090,0004.74%
Lion Point Capital, LP 1,164,414$18,840,0004.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 4,503,900$72,873,0003.52%
ARMISTICE CAPITAL, LLC 650,000$10,517,0002.49%
SCOPIA CAPITAL MANAGEMENT LP 8,081,650$130,761,0002.48%
View complete list of HORIZON PHARMA PLC shareholders